Literature DB >> 20133777

Identification and functional characterization of paxillin as a target of protein tyrosine phosphatase receptor T.

Yiqing Zhao1, Xiaodong Zhang, Kishore Guda, Earl Lawrence, Qun Sun, Toshio Watanabe, Yoichiro Iwakura, Masahide Asano, Lanlan Wei, Zhirong Yang, Weiping Zheng, Dawn Dawson, Joseph Willis, Sanford D Markowitz, Masanobu Satake, Zhenghe Wang.   

Abstract

Protein tyrosine phosphatase receptor-type T (PTPRT) is the most frequently mutated tyrosine phosphatase in human cancers. However, the cell signaling pathways regulated by PTPRT largely remain to be elucidated. Here, we show that paxillin is a direct substrate of PTPRT and that PTPRT specifically regulates paxillin phosphorylation at tyrosine residue 88 (Y88) in colorectal cancer (CRC) cells. We engineered CRC cells homozygous for a paxillin Y88F knock-in mutant and found that these cells exhibit significantly reduced cell migration and impaired anchorage-independent growth, fail to form xenograft tumors in nude mice, and have decreased phosphorylation of p130CAS, SHP2, and AKT. PTPRT knockout mice that we generated exhibit increased levels of colonic paxillin phosphorylation at residue Y88 and are highly susceptible to carcinogen azoxymethane-induced colon tumor, providing critical in vivo evidence that PTPRT normally functions as a tumor suppressor. Moreover, similarly increased paxillin pY88 is also found as a common feature of human colon cancers. These studies reveal an important signaling pathway that plays a critical role in colorectal tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20133777      PMCID: PMC2823898          DOI: 10.1073/pnas.0914884107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

Review 1.  Oncogenic kinase signalling.

Authors:  P Blume-Jensen; T Hunter
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

2.  Tyrosine phosphorylation of paxillin alpha is involved in temporospatial regulation of paxillin-containing focal adhesion formation and F-actin organization in motile cells.

Authors:  K Nakamura; H Yano; H Uchida; S Hashimoto; E Schaefer; H Sabe
Journal:  J Biol Chem       Date:  2000-09-01       Impact factor: 5.157

3.  Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors.

Authors:  K Pietras; A Ostman; M Sjöquist; E Buchdunger; R K Reed; C H Heldin; K Rubin
Journal:  Cancer Res       Date:  2001-04-01       Impact factor: 12.701

4.  15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis.

Authors:  Seung-Jae Myung; Ronald M Rerko; Min Yan; Petra Platzer; Kishore Guda; Angela Dotson; Earl Lawrence; Andrew J Dannenberg; Alysia Kern Lovgren; Guangbin Luo; Theresa P Pretlow; Robert A Newman; Joseph Willis; Dawn Dawson; Sanford D Markowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-31       Impact factor: 11.205

5.  Mutational inactivation of PTPRD in glioblastoma multiforme and malignant melanoma.

Authors:  David A Solomon; Jung-Sik Kim; Julia C Cronin; Zita Sibenaller; Timothy Ryken; Steven A Rosenberg; Habtom Ressom; Walter Jean; Darell Bigner; Hai Yan; Yardena Samuels; Todd Waldman
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

Review 6.  Paxillin: a focal adhesion-associated adaptor protein.

Authors:  M D Schaller
Journal:  Oncogene       Date:  2001-10-01       Impact factor: 9.867

Review 7.  Targeting the phosphoinositide 3-kinase pathway in cancer.

Authors:  Pixu Liu; Hailing Cheng; Thomas M Roberts; Jean J Zhao
Journal:  Nat Rev Drug Discov       Date:  2009-08       Impact factor: 84.694

8.  The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers.

Authors:  Selvaraju Veeriah; Cameron Brennan; Shasha Meng; Bhuvanesh Singh; James A Fagin; David B Solit; Philip B Paty; Dan Rohle; Igor Vivanco; Juliann Chmielecki; William Pao; Marc Ladanyi; William L Gerald; Linda Liau; Timothy C Cloughesy; Paul S Mischel; Chris Sander; Barry Taylor; Nikolaus Schultz; John Major; Adriana Heguy; Fang Fang; Ingo K Mellinghoff; Timothy A Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-28       Impact factor: 11.205

Review 9.  Paxillin comes of age.

Authors:  Nicholas O Deakin; Christopher E Turner
Journal:  J Cell Sci       Date:  2008-08-01       Impact factor: 5.285

10.  Tumor-derived extracellular mutations of PTPRT /PTPrho are defective in cell adhesion.

Authors:  Jianshi Yu; Scott Becka; Peng Zhang; Xiaodong Zhang; Susann M Brady-Kalnay; Zhenghe Wang
Journal:  Mol Cancer Res       Date:  2008-07       Impact factor: 5.852

View more
  43 in total

Review 1.  Tumour suppressor function of protein tyrosine phosphatase receptor-T.

Authors:  Anthony Scott; Zhenghe Wang
Journal:  Biosci Rep       Date:  2011-10       Impact factor: 3.840

Review 2.  Delving into somatic variation in sporadic melanoma.

Authors:  Vijay Walia; Euphemia W Mu; Jimmy C Lin; Yardena Samuels
Journal:  Pigment Cell Melanoma Res       Date:  2012-02-13       Impact factor: 4.693

3.  Cancer-derived mutations in the fibronectin III repeats of PTPRT/PTPrho inhibit cell-cell aggregation.

Authors:  Peng Zhang; Scott Becka; Sonya E L Craig; David T Lodowski; Susann M Brady-Kalnay; Zhenghe Wang
Journal:  Cell Commun Adhes       Date:  2009-12

4.  Association analysis identifies new risk loci for congenital heart disease in Chinese populations.

Authors:  Yuan Lin; Xuejiang Guo; Bijun Zhao; Juanjuan Liu; Min Da; Yang Wen; Yuanli Hu; Bixian Ni; Kai Zhang; Shiwei Yang; Jing Xu; Juncheng Dai; Xiaowei Wang; Yankai Xia; Hongxia Ma; Guangfu Jin; Shiqiang Yu; Jiayin Liu; Bernard D Keavney; Judith A Goodship; Heather J Cordell; Xinru Wang; Hongbing Shen; Jiahao Sha; Zuomin Zhou; Yijiang Chen; Xuming Mo; Lingfei Luo; Zhibin Hu
Journal:  Nat Commun       Date:  2015-08-18       Impact factor: 14.919

5.  DNMT1 stability is regulated by proteins coordinating deubiquitination and acetylation-driven ubiquitination.

Authors:  Zhanwen Du; Jing Song; Yong Wang; Yiqing Zhao; Kishore Guda; Shuming Yang; Hung-Ying Kao; Yan Xu; Joseph Willis; Sanford D Markowitz; David Sedwick; Robert M Ewing; Zhenghe Wang
Journal:  Sci Signal       Date:  2010-11-02       Impact factor: 8.192

6.  Overexpression of Paxillin Correlates with Tumor Progression and Predicts Poor Survival in Glioblastoma.

Authors:  Li-Hua Sun; Fu-Qiang Yang; Chuan-Bao Zhang; Yi-Ping Wu; Jing-Shan Liang; Shuai Jin; Zheng Wang; Hong-Jun Wang; Zhao-Shi Bao; Zheng-Xiang Yang; Tao Jiang
Journal:  CNS Neurosci Ther       Date:  2016-09-17       Impact factor: 5.243

7.  p190RhoGEF (Rgnef) promotes colon carcinoma tumor progression via interaction with focal adhesion kinase.

Authors:  Hong-Gang Yu; Ju-Ock Nam; Nichol L G Miller; Isabelle Tanjoni; Colin Walsh; Lei Shi; Linda Kim; Xiao Lei Chen; Alok Tomar; Ssang-Taek Lim; David D Schlaepfer
Journal:  Cancer Res       Date:  2011-01-11       Impact factor: 12.701

8.  MicroRNA-145 suppresses cell migration and invasion by targeting paxillin in human colorectal cancer cells.

Authors:  Jun Qin; Feiran Wang; Haiyan Jiang; Junfei Xu; Yasu Jiang; Zhiwei Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

9.  Holo-retinol-binding protein and its receptor STRA6 drive oncogenic transformation.

Authors:  Daniel C Berry; Liraz Levi; Noa Noy
Journal:  Cancer Res       Date:  2014-09-18       Impact factor: 12.701

10.  Diverse roles for the paxillin family of proteins in cancer.

Authors:  Nicholas O Deakin; Jeanine Pignatelli; Christopher E Turner
Journal:  Genes Cancer       Date:  2012-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.